When does the Pylarify (piflufolastat F 18) patent expire?
No usable patent-expiry date for “Pylarify” could be confirmed from the information provided. Patent life depends on the specific patent(s) covering the drug substance, formulation, manufacturing process, and method-of-use, as well as patent terms and any extensions or regulatory exclusivities tied to the product’s approval in each country.
What determines Pylarify’s effective monopoly date (not just the first patent expiry)?
Even if one patent expires, the marketed product can stay protected by:
- Other, still-active patents on composition, formulation, or manufacturing.
- Method-of-use patents that restrict how the drug can be used clinically.
- Country-specific regulatory protections (for example, exclusivity regimes) that can delay generic or biosimilar entry even after patent expiry.
Which patents should be checked to estimate Pylarify’s earliest expiry?
For a defensible timeline, you typically check the patent family for the product and related claims, such as:
- Drug substance patents (active ingredient).
- Drug product/formulation patents (how it is made and packaged).
- Radiolabeling/manufacturing-process patents.
- Method-of-use claims relevant to imaging protocols.
How can you find the exact Pylarify expiry date for your country?
To get the real “expiry” date you’re looking for, you need to pull the relevant patent numbers from:
- The national patent registry (e.g., USPTO in the U.S., EPO for Europe, and Japan/Korea equivalents).
- The product’s regulatory record and any linked patent listings used by regulators for market-exclusivity tracking.
- Patent-family databases that show term dates and legal status (grants, expirations, and any extensions).
Quick clarification to get you a precise answer
Which jurisdiction do you mean by “Pylarify patent expiry” (U.S., EU, UK, Canada, Japan, or another)? If you tell me the country (and whether you want the earliest patent expiry, or the last one before generics can enter), I can focus the search on the relevant patent listings and compute the effective end date.